SCHEMBL29673268

SCHEMBL29673268

N#Cc1cc(-c2nnc(-c3ccc4[nH]cnc4c3)o2)ccc1F

nearest known ligand 0.44

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 20/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20587550 1.00 QPCT (0.44) QPCT
SCHEMBL30355519 0.80 QPCT (0.41) QPCT
SCHEMBL23524394 0.80 QPCT (0.41) QPCT
SCHEMBL30355516 0.79 QPCT (0.41) QPCT
SCHEMBL23524006 0.79 QPCT (0.41) QPCT
SCHEMBL23524340 0.79 QPCT (0.40) QPCT
SCHEMBL23523965 0.79 QPCT (0.40) QPCT
SCHEMBL23558413 0.79 QPCT (0.40) QPCT
SCHEMBL30355632 0.79 QPCT (0.40) QPCT
SCHEMBL30355504 0.79 QPCT (0.40) QPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114585360-B Methods of using the same for treating epilepsy 特维娜有限公司 2025-04-29 CN disclosed
CN-114585360-A Methods of using the same for the treatment of epilepsy 特维娜有限公司 2022-06-03 CN disclosed